Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 807-789-8 | CAS number: 111062-42-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
In a bacterial reverse mutation assay, test article did not meet the criteria for a potential mutagen.
In an in vitro TK mutation bioassy, the test article did not induce a biologically relevant increase in the mutation frequency in the, either in the presence or absence of a metabolic activation system (S9-mix).
In an in vitro chromosome aberration assay, the test article was not considered to be genotoxic when exposed to Chinese Hamster Ovary (CHO) cells either in the presence and absence of S9 metabolic activation.
Link to relevant study records
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 21 March to 04 May, 2018
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Version / remarks:
- 1997
- GLP compliance:
- yes
- Remarks:
- US FDA (21 CFR Parts 58, 210, 211, and 820) Regulations
- Type of assay:
- bacterial reverse mutation assay
- Specific details on test material used for the study:
- Test Article: Agent 447C; 1-octanol, reaction products with phosphorus oxide (P2Os), potassium salts (CAS 111062-42-1 ; EC 807-789-8)
- Species / strain / cell type:
- S. typhimurium, other: TA97A, TA98, TA100, TA1535
- Species / strain / cell type:
- E. coli WP2
- Metabolic activation:
- with and without
- Metabolic activation system:
- S-9, rat liver
- Test concentrations with justification for top dose:
- 5 μL, 1.6 μL, 0.5 μL, 0.16 μL, 0.05 μL/plate
The concentrations tested were based on the OECD 471 highest recommended concentration for non-cytotoxic compounds. - Vehicle / solvent:
- The test article was diluted in sterile water
- Untreated negative controls:
- not specified
- Negative solvent / vehicle controls:
- yes
- Remarks:
- sterile water
- True negative controls:
- not specified
- Positive controls:
- yes
- Positive control substance:
- sodium azide
- methylmethanesulfonate
- other: 4-nitro-0-phenylenediamine (tested without S-9 metabolic activation only), 2-aminofluorene (tested with S-9 metabolic activation only), 2-aminoanthracene (tested with S-9 metabolic activation only)
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in agar (plate incorporation)
- Cell density at seeding: the titers of each strain culture had concentrations of approximately 10E8 CFU/mL or higher
DURATION
- Exposure duration: The plates were incubated for growth at 37 ± 2°C for 48-72 hours.
NUMBER OF REPLICATIONS: 3 replicates for each test article or control were prepared. - Evaluation criteria:
- Criteria for a Mutagen:
1) A reversion rate greater than 200% of the solvent control in strains TA97a and TA 100. A reversion rate greater than 300% of the solvent control in strains TA98,TA1535, and WP2.
2) Demonstration of a clear dose related response when dilutions are tested.
Criteria for a Non-Mutagen:
1) A reversion rate less than or equal to 200% of the solvent control in strains TA97a and TA 100. A reversion rate less than or equal to 300% of the solvent control in strains TA98, TA 1535, and WP2.
2) No dose related response when dilutions are tested. - Statistics:
- The results were calculated using a validated computer program. Manual calculations may have differed slightly due to rounding. All results greater than 300 colony forming units (CFU) were considered estimates.
- Species / strain:
- S. typhimurium, other: TA97a
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- At the highest test article concentration (5 µL/plate) without metabolic activation
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not specified
- Positive controls validity:
- valid
- Species / strain:
- S. typhimurium TA 98
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- not specified
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not specified
- Positive controls validity:
- valid
- Species / strain:
- S. typhimurium TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- not specified
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not specified
- Positive controls validity:
- valid
- Species / strain:
- S. typhimurium TA 1535
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- not specified
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not specified
- Positive controls validity:
- valid
- Species / strain:
- E. coli WP2
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- not specified
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not specified
- Positive controls validity:
- valid
- Conclusions:
- The test article concentrations of 5 μL, 1.6 μL, 0.5 μL, 0.16 μL, 0.05 μL/plate did not produce a two-fold or three-fold increase in the number of revertants nor produce a clear dose related response in any of the 5 tester strains (S. typhimurium tester strains TA97a, TA98, TA100, and TA1535, and E. coli test strain WP2). The spot tests showed no zone of increased reversion or of toxicity. In summary, the test article concentrations tested against the five strains did not meet the criteria for a potential mutagen.
- Endpoint:
- in vitro cytogenicity / chromosome aberration study in mammalian cells
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 04 April 2018 to 14 June 2018
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study
- Remarks:
- OECD 473
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 473 (In Vitro Mammalian Chromosome Aberration Test)
- Version / remarks:
- 2016
- GLP compliance:
- yes
- Type of assay:
- in vitro mammalian chromosome aberration test
- Specific details on test material used for the study:
- Test material identity: Agent 447C; 1-Octanol, reaction products with phosphorus oxide (P2O5), potassium salts (CAS 111062-42-1; EG 807-789-8)
- Species / strain / cell type:
- Chinese hamster Ovary (CHO)
- Details on mammalian cell type (if applicable):
- - CHO cells were obtained from ATCC and were certified mycoplasma-free.
- cell line has an average generation time of approximately 12-13 hours.
- cells were passed a maximum of 14 times at Nelson Laboratories. - Metabolic activation:
- with and without
- Metabolic activation system:
- S9 homogenate; obtained from Moltox; prepared from 8-10 week old Sprague Dawley male rats injected intraperitoneally with Aroclor 1254.
- Test concentrations with justification for top dose:
- 0.05 μL/mL, 0.016 μL/mL, and 0.005 μL/mL. Dose determination studies were performed to find concentrations that were compatible with the test system.
- Untreated negative controls:
- yes
- Remarks:
- USP Sterile Water
- Positive controls:
- yes
- Positive control substance:
- cyclophosphamide
- mitomycin C
- Details on test system and experimental conditions:
- METHOD OF APPLICATION:
- incubated with Kaighn's Modification of Ham's F-12 Medium + 10% Fetal Bovine Serum (F12K10) until 40-60% confluent.
- Cell density at seeding (if applicable): Approximately 9.5x10^5 - 2.0x10^6 cells were seeded into 75 cm2 cell culture flasks.
DURATION
- Exposure duration:
For the non-activated system: flasks incubated for 16-18 hours at 37 ± 1°C with 5 ± 1% CO2.
For the metabolic activation system: flasks exposed for 3-4 hours at 37 ± 1°C with 5 ± 1% CO2. Cells then incubated at 37 ± 1°C with 5 ± 1% CO2 for 15-21 hours.
- Expression time (cells in growth medium): At the end of the exposure and expression periods the cells were arrested in metaphase with colcemid for 2 hours ± 30 minutes.
STAIN (for cytogenetic assays):
- chromosomes were stained with Giemsa stain
NUMBER OF REPLICATIONS: The negative control, positive control, and test articles were tested in duplicate.
METHODS OF SLIDE PREPARATION AND STAINING TECHNIQUE USED:
- cells were removed from the flasks and treated with a 75 mM KCI hypotonic solution and fixative. The cells were dropped onto clean and cold microscope slides. The chromosomes were stained with Giemsa stain and coverslips were secured to the slides with mounting medium. The cells were then examined microscopically for chromosome aberrations.
DETERMINATION OF CYTOTOXICITY
- Method: degree of discernable morphological cytotoxicity on a relative scale of 0 to 4. - Evaluation criteria:
- - Cells with 20 ± 2 chromosomes, with minimal overlapping, were scored for aberrations.
- Cells scored based on number of aberrant cells. Total cells scored = 300.
- Cytotoxicity assessed via types of aberrations assessed included: gaps, simple breaks, complex aberrations (e.g., dicentric, quadradial, ring, interstitial deletion, complex rearrangement), and other (pulverized, >10). - Statistics:
- Results were evaluated with the chi-square calculation using a validated spreadsheet. The critical value for the chi-square test is 3.841 at a confidence level of 95%.
- Key result
- Species / strain:
- Chinese hamster Ovary (CHO)
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Remarks:
- test article is not considered to be genotoxic when exposed to CHO cells
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Remarks:
- cytotoxicity data showed no significant reactivity to the test article solution when placed on CHO cells
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Conclusions:
- 1-Octanol, reaction products with phosphorus oxide (P2O5), potassium salts is not considered to be genotoxic at concentrations of 0.05 µL/mL, 0.016 µL/mL, and 0.005 µL/mL when exposed to Chinese Hamster Ovary (CHO) cells both in the presence and absence of S9 metabolic activation.
- Endpoint:
- in vitro gene mutation study in mammalian cells
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- Mar 2019 to May 2019
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 490 (In Vitro Mammalian Cell Gene Mutation Tests Using the Thymidine Kinase Gene)
- Version / remarks:
- 2016
- GLP compliance:
- yes
- Type of assay:
- in vitro mammalian cell gene mutation tests using the thymidine kinase gene
- Specific details on test material used for the study:
- Purity/Composition: UVCB; solid matter 41.4%
- Target gene:
- forward mutations at the thymidine kinase (TK) locus in L5178Y mouse lymphoma cells
- Species / strain / cell type:
- mouse lymphoma L5178Y cells
- Details on mammalian cell type (if applicable):
- CELLS USED
- Type and source of cells: American Type Culture Collection - Metabolic activation:
- with and without
- Metabolic activation system:
- Type and composition of metabolic activation system:
- source of S9 : Rat liver microsomal enzymes from Trinova Biochem GmbH, Giessen, Germany from male Sprague Dawley rats that have been dosed orally with a suspension of phenobarbital (80 mg/kg body weight) and ß-naphthoflavone (100 mg/kg body weight)
- method of preparation of S9 mix: S9-mix components contained per mL physiological saline: 1.63 mg MgCl2.6H2O; 2.46 mg KCl; 1.7 mg glucose-6-phosphate; 3.4 mg NADP, 4 μmol HEPES. The above solution was filter (0.22 μm)-sterilized. To 0.5 mL S9-mix components 0.5 mL S9-fraction was added (50% (v/v) S9-fraction) to complete the S9-mix.
- concentration or volume of S9 mix and S9 in the final culture medium: 4% (v/v) - Test concentrations with justification for top dose:
- Without activation: 1, 5, 10, 30, 60, 90, 100, 110 µg/mL
With activation: 1, 5, 10, 30, 60, 100, 120, 140 µg/mL
corrected for the % solid matter (41.4%) - Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: water
- Justification for choice of solvent/vehicle: marketed as an aqueous solution - Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- Remarks:
- water
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- cyclophosphamide
- methylmethanesulfonate
- Details on test system and experimental conditions:
- In the first experiment, the test item was tested up to concentrations of 110 μg/mL and 140 μg/mL in the absence and presence S9-mix, respectively. The incubation time was 3 hours.
In the second experiment, the test item was tested up to concentrations of 170 μg/mL in the absence of S9-mix.
METHODS FOR MEASUREMENT OF CYTOTOXICITY
The cloning efficiency (CE) was then calculated as follows: CE = -ln P(0)/number of cells plated per well
The Relative Total Growth (RTG) was also calculated as the product of the cumulative relative suspension growth (RSG) and the relative survival for each culture: RTG = RSG x RCE/100 - Evaluation criteria:
- A mutation assay was considered acceptable if it met the following criteria:
a) The absolute cloning efficiency of the solvent controls (CE-day2) is between 65 and 120% in order to have an acceptable number of surviving cells analyzed for expression of the TK mutation.
b) The spontaneous mutation frequency in the solvent control is ≥ 50 per 10E6 survivors and ≤ 170 per 10E6 survivors.
c) The suspension growth (SG) over the 2-day expression period for the solvent controls should be between 8 and 32 for the 3 hour treatment, and between 32 and 180 for the 24 hour treatment.
d) The positive control should demonstrate an absolute increase in the total mutation frequency, that is, an increase above the spontaneous background MF (an induced MF (IMF)) of at least 300 x 10E-6. At least 40% of the IMF should be reflected in the small colony MF. And/or, the positive control has an increase in the small colony MF of at least 150 x 10E-6 above that seen in the concurrent solvent control (a small colony IMF of 150 x 10E-6). - Statistics:
- In addition to the criteria stated below, any increase of the mutation frequency should be evaluated for its biological relevance including comparison of the results with the historical control data range.
The global evaluation factor (GEF) has been defined by the IWGT as the mean of the negative/solvent MF distribution plus one standard deviation. For the micro well version of the assay the GEF is 126.
A test item is considered positive (mutagenic) in the mutation assay if it induces a MF of more than MF(controls) + 126 in a dose-dependent manner. An observed increase should be biologically relevant and will be compared with the historical control data range.
A test item is considered equivocal (questionable) in the mutation assay if no clear conclusion for positive or negative result can be made after an additional confirmation study.
A test item is considered negative (not mutagenic) in the mutation assay if: none of the tested concentrations reaches a mutation frequency of MF(controls) + 126. - Species / strain:
- mouse lymphoma L5178Y cells
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- True negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Additional information on results:
- The mutation frequency found in the solvent control cultures was within the acceptability criteria of this assay and within the 95% control limits of the distribution of the historical negative control database.
Positive control chemicals, methyl methanesulfonate and cyclophosphamide, both produced significant increases in the mutation frequency. In addition, the mutation frequency found in the positive control cultures was within the 95% control limits of the distribution of the historical positive control database. It was therefore concluded that the test conditions were adequate and that the metabolic activation system (S9-mix) functioned properly.
The suspension growth over the two-day expression period for cultures treated with Milli-Q Water was between 12 and 13 (3 hour treatment) and 83 and 90 (24 hour treatment). - Conclusions:
- The test item is not mutagenic in the TK mutation test system under the experimental conditions described in this report.
- Executive summary:
The objective of this study was to evaluate the mutagenic potential of 1-Octanol, reaction products with phosphorus oxide (P2O5), potassium salts by testing its ability to induce forward mutations at the thymidine kinase (TK) locus in L5178Y mouse lymphoma cells, either in the absence or presence of a metabolic system (S9-mix). The TK mutational system detects base pair mutations, frame shift mutations and small deletions.
The test was performed in the absence of S9-mix with 3 and 24 hour treatment periods and in the presence of S9-mix with a 3 hour treatment period.
The study procedures were based on the most recent OECD guideline.
The test item was a colourless-light yellowish liquid. A correction factor of 2.42 was used to correct for the % solid matter (41.4%). The vehicle of the test item was Milli-Q water.
In the first experiment, the test item was tested up to concentrations of 110 μg/mL and 140 μg/mL in the absence and presence S9-mix, respectively. The incubation time was 3 hours. Relative total growth (RTG) was reduced to 14% and 8% in the absence and presence of S9-mix, respectively.
In the second experiment, the test item was tested up to concentrations of 170 μg/mL in the absence of S9-mix. The incubation time was 24 hours. The RTG was reduced to 8%.
The mutation frequency found in the solvent control cultures was within the acceptability criteria of this assay and within the 95% control limits of the distribution of the historical negative control database.
Positive control chemicals, methyl methanesulfonate and cyclophosphamide, both produced significant increases in the mutation frequency. In addition, the mutation frequency found in the positive control cultures was within the 95% control limits of the distribution of the historical positive control database. It was therefore concluded that the test conditions were adequate and that the metabolic activation system (S9-mix) functioned properly.
In the absence of S9-mix, the test item did not induce a biologically relevant increase in the mutation frequency in the first experiment. This result was confirmed in an independent experiment with modification in the duration of treatment.
In the presence of S9-mix, the test item did not induce a biologically relevant increase in the mutation frequency.
In conclusion, the test item is not mutagenic in the mouse lymphoma L5178Y test system under these experimental conditions.
Referenceopen allclose all
The criteria for acceptance of the test and criteria for determination of a mutagen were:
1) Tested strains for phenotype verification and achieved the appropriate responses.
2) All chemical controls included in the test gave the appropriate responses.
a) for TA97a: % of control results >200 qualify as a positive
b) for TA98: % of control results >300 qualify as a positive
c) for TA100: % of control results >200 qualify as a positive
d) for TA1535: % of control results >300 qualify as a positive
e) for WP2: % of control results >300 qualify as a positive
3) The reversion rates for each tester strain were within the historical ranges (from 2016)
Test Method Acceptance Criteria:
The following conditions were met, thus the data was considered acceptable:
1. Positive results compared to the negative control were higher than the critical chi-square value of 3.841 at a confidence interval of 95%.
2. The average percent aberrations for the controls were within the historical control limits set in the test procedure(s).
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Additional information
Justification for classification or non-classification
The in vitro testing available did not meet the criteria for a classification as a potential mutagen. Therefore, the substance does not meet the criteria for classification as a germ cell mutagen according to CLP (EC 1272/2008 as amended).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.